简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2021-01-13 13:22 HD Medical at CES Unveils HealthyU™, the World’s First Intelligent All-in-one Remote Patient Monitor for Telehealth and Wellness
2021-01-12 17:23 Boehringer Ingelheim and Enara Bio Enter Strategic Collaboration and Licensing Agreement to Discover Novel Shared Antigens for Cancer Immunotherapies
2021-01-12 16:09 P&G Commits to Enable 2 Billion People to Adopt Healthy Oral Care Habits by 2030
2021-01-12 15:50 Octapharma to Demonstrate Ongoing Commitment to Improving the Long-term Health of People With Haemophilia A at the 14th EAHAD Annual Congress
2021-01-12 15:16 Takeda to Present at The 39th Annual J.P. Morgan Healthcare Conference
2021-01-12 10:01 NEC Releases “WISE VISION Endoscopy” in Europe and Japan
2021-01-12 09:59 Underscoring Critical Role of Science in a Smoke-Free Future, Philip Morris International Brings on Former Sanofi Exec as Chief Life Sciences Officer
2021-01-11 17:27 Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D
2021-01-11 15:18 RACING to Bring Life Back to Life
2021-01-11 14:13 Crown Bioscience Expands Genomics and Next Generation Sequencing (NGS) Capabilities To Streamline Translational Biomarker Discovery Workflows
2021-01-08 09:24 LG Chem to Contribute to Global Polio Eradication with Eupolio™, the First Sabin Inactivated Polio Vaccine to Receive WHO Prequalification
2021-01-08 09:21 Pi-Cardia Successfully Treats First Patients with ShortCut™ Device
2021-01-07 17:52 COVID-19 Vaccine Logistics Chain Reliability and Compliance
2021-01-06 16:43 ZOLL Medical’s Advanced Defibrillators Win Five-Star World of Safety & Health Asia Award 2020
2021-01-06 14:37 rf IDEAS Delivers WAVE ID® Secure Access Technology for LG Electronics
2021-01-06 14:04 Ringing in the New Year With a New Name! Shinkowa Pharmaceutical Co., Ltd., Is Now MIRAILAB BIOSCIENCE Inc.
2021-01-06 12:06 Takeda Completes Sale of Select Non-Core Assets to Cheplapharm
2021-01-04 10:00 IO Biosciences Awarded US Patent for GEMSTM Technology, Promising Breakthrough for Those Engineering Antibody Therapies and Therapeutic Gene-modified Immune Cells
2020-12-30 17:58 Celltrion Submits Application for Conditional Marketing Authorisation of Its COVID-19 Treatment Candidate CT-P59 to the Korean MFDS
2020-12-25 09:58 Novaremed Receives Fast Track Designation from the FDA for NRD135S.E1 for the Treatment of Painful Diabetic Peripheral Neuropathy

Business Wire Weibo

Press Releases

Latest Releases